UroGen Pharma Ltd. Quarterly Common Stock, Shares, Outstanding from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
UroGen Pharma Ltd. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2016 to Q3 2024.
  • UroGen Pharma Ltd. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 42.2M shares, a 0.02% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 42.2M -9.19K -0.02% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 41.2M +17.7M +75.2% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 36.1M +12.7M +54.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 32.5M +9.36M +40.5% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 42.2M +19.2M +83.4% Sep 30, 2023 10-Q 2024-11-06
Q2 2023 23.5M +771K +3.39% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 23.4M +758K +3.34% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 23.1M +667K +2.97% Dec 31, 2022 10-K 2024-03-14
Q3 2022 23M +606K +2.71% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 22.7M +373K +1.67% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 22.7M +402K +1.8% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 22.5M +295K +1.33% Dec 31, 2021 10-K 2023-03-24
Q3 2021 22.4M +333K +1.51% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 22.4M +353K +1.61% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 22.3M +1.07M +5.03% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 22.2M +1.14M +5.43% Dec 31, 2020 10-K 2022-03-21
Q3 2020 22.1M +1.13M +5.38% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 22M +1.15M +5.52% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 21.2M +455K +2.19% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 21M +4.81M +29.7% Dec 31, 2019 10-K 2021-03-18
Q3 2019 20.9M +4.84M +30.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 20.8M +5M +31.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 20.8M +5.28M +34.2% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 16.2M +2.46M +17.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 16.1M Sep 30, 2018 6-K 2018-11-13
Q2 2018 15.9M Jun 30, 2018 6-K 2018-08-14
Q1 2018 15.5M Mar 31, 2018 6-K 2018-05-15
Q4 2017 13.8M +11.4M +496% Dec 31, 2017 10-K 2019-02-28
Q4 2016 2.31M Dec 31, 2016 20-F 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.